TetraLogic Pharmaceuticals (OTCMKTS:TLOG) Share Price Crosses Above Two Hundred Day Moving Average – What’s Next?

TetraLogic Pharmaceuticals Corporation (OTCMKTS:TLOG) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. TetraLogic Pharmaceuticals shares last traded at $0.0001, with a volume of 300 shares traded.

TetraLogic Pharmaceuticals Stock Up 9,900.0%

TetraLogic Pharmaceuticals Company Profile

TetraLogic Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel immunotherapies and small-molecule therapeutics for the treatment of cancer and infectious diseases. Its primary focus is on synthetic carbohydrate-based vaccines that stimulate targeted immune responses against tumor-associated antigens, complemented by a small-molecule antibiotic platform designed to combat drug-resistant bacterial pathogens.

The company’s lead immunotherapy candidate, which targets mucin-based tumor antigens, is under evaluation in early-phase clinical trials in collaboration with academic research centers, with particular emphasis on breast and ovarian cancer indications.